InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the complete record of transactions filed by Håkan Englund, Director. Insider active across 1 company, notably Prostatype Genomics AB. In total, 2 disclosures have been published. History available since 4 June 2025. The latest transaction was disclosed on 29 July 2026 (Purchase). Regulator: FIN-FSA. The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations
Håkan Englund is a board member of Prostatype Genomics AB. He plays a crucial role in the strategic direction of the company, participating in board meetings and contributing to important decision-making. Prostatype Genomics AB focuses on developing innovative solutions in the field of genomics, aiming to improve treatments for patients.